Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Philip Morris International Inc. (PM): A Smoking Hot International Opportunity

Philip Morris International Inc. (NYSE:PM) owns the #1 cigarette brand in the world, Marlboro, along with other brands such as L&M, Fortune, Bond Street, Parliament, Red & White, and Virginia Slims. They also own a small cigar segment and have been growing its position in smokeless tobacco such as Swedish snus. Smoking cigarettes in the United States has become known as “disgusting,” or as being a bad habit, but internationally this is not the case.

Philip Morris International Inc. (NYSE:PM)As sales in America have slowed, sales outside of America are raging on. For this reason, consider Philip Morris a much better play than its parent company Altria Group, Inc. (NYSE:MO), who handles sales within the United States. This is also the reasoning for picking Philip Morris International Inc. (NYSE:PM) over Reynolds American, Inc. (NYSE:RAI) and Lorillard Inc. (NYSE:LO). Both of these companies manufacture and sell cigarettes in the United States, which is not where the major growth lies. Reynolds’ brands include Camel, Pall Mall, Winston, Salem, and American Snuff. Lorillard’s brands include Newport, Maverick, Kent, Old Gold, and Kent. As you can see, the more popular brands lie with Philip Morris International, but the others still have strong positions in the market.

Philip Morris International is currently trading at $86.97 on Feb. 4, with earnings of $5.00 per share. At this price, it is trading at just 17.39 times earnings and 15.02 times 2013 projected earnings. These are great numbers, but what really sticks out is the company is projected to have earnings of $6.42 per share in 2014. This would make it currently trading at just 13.5 times those earnings. These multiples are much too low for the growth Philip Morris International has the potential to achieve in the next few years. Altria, Reynolds American, and Lorillard all have positive growth rates going forward, but not as high as this company.

My favorite statistic of Philip Morris International is that they pay out a terrific $3.40 dividend, representing a 3.91% yield. This dividend has been raised each of the last 4 years, including a recent 10%+ raise. Altria Group, the parent company, has raised its dividend for 47 consecutive years. There is no reason that Philip Morris International will not follow directly in their footsteps. Altria, Reynolds American, and Lorillard all currently have higher dividends, but with growth factored in, they do not rise to the top of the list. Altria currently yields 5.15%, Reynolds yields 5.38%, and Lorillard yields 5.2%. If you are looking for dividend income with smaller returns from overall gains, one of these may be your better bet.

With all of this said, Philip Morris International is incredibly cheap. The current industry average for price to earnings is 19.86, which would value this company around $99 per share. I project that the stock will return above $90 per share by the end of the first quarter and will surpass $104 in 2013 based on 18 times earnings. Even if the stock were to trade sideways for a while, the solid 3.86% dividend will pay to wait for the move higher. I am initiating an outperform on CAPS. Altria, Reynolds American, and Lorillard are all BUYS. Philip Morris International is a STRONG BUY.

The article A Smoking Hot International Opportunity originally appeared on and is written by Joseph Solitro.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!